Interview with Kewal Handa, Managing Director, Pfizer Limited India
To start off, can you tell us how you have seen the pharmaceutical industry developing in India? Has the perception…
Pfizer Limited India
Last updated: 13.02.2014
Address: Pfizer Centre,
5, Patel Estate, S V Road,
Jogeshwari (West),
Mumbai – 400 102.
Tel: 022 – 6693 2000
Web: http://www.pfizerindia.com/eNewsWebsite/index.aspx
Company description
• Pfizer Limited (India) has a turnover of US$ 165.86 million (November 2009)
• One of the highest spenders in pharmaceutical R&D globally, Pfizer has made clinical research investments of US$ 6.28 million (November 2009) in India
• The company was awarded the FICCI SEDF (Socio Economic Development Foundation) Certificate of Commendation for its social responsibility efforts
• Pfizer has won several awards including that for the multinational pharmaceutical company of the year and the most respected MNC
Products and services
• Six Pfizer brands feature among the Top 100 pharmaceutical brands in India
• Two of Pfizer India’s brands — Corex (Cough Formulation) and Becosules (Multivitamin) — continue to rank among the Top 10 pharmaceutical drug brands
• Pfizer has won the Golden Peacock Innovative Product for Magnex (Sulperazon)
• Becosules has won the Most Trusted Brand Award
Interviews
Related
India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
India / Pharma Market to Grow by 12-14% Up to 2023
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
India / Six Companies at the Forefront of COVID-19 Vaccine Development
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
Supply Chain / Indian Pharma Manufacturing: Back in Business
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
News Roundup / Indian Pharma: January 2020
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
India / Biocon's New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
Gujarat / The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Pharma Faces / Vivek Sharma, PPS
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
China: Indian Pharma Firms Incoming
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
